Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Jul 27;161(2):165–170.

Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation

M J Nowaczyk 1, D T Whelan 1, T W Heshka 1, R E Hill 1
PMCID: PMC1230468  PMID: 10439827

Abstract

Smith-Lemli-Opitz syndrome, a syndrome of multiple malformations and mental retardation that for years was relegated to the atlases of genetic esoterica, was recently found to be a relatively common inborn error of metabolism. The underlying defect is absent or deficient activity of 7-dehydrocholesterol- delta 7-reductase, the enzyme catalysing the final step of cholesterol synthesis. The discovery of the biochemical defect causing Smith-Lemli-Opitz syndrome has resulted in the development of a diagnostic test and a potentially beneficial treatment (dietary cholesterol supplementation). Infants and young children with the syndrome have shown marked improvement in growth, behaviour and general health after receiving cholesterol therapy; older children and adults have shown some improvement in development and intellectual functioning. Despite the excitement these developments have elicited among geneticists and biochemists, this syndrome remains relatively unknown to many primary care physicians. Increased awareness of Smith-Lemli-Opitz syndrome is needed to identify affected patients so that they and their families can benefit from appropriate treatment and genetic counselling.

Full Text

The Full Text of this article is available as a PDF (591.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bialer M. G., Penchaszadeh V. B., Kahn E., Libes R., Krigsman G., Lesser M. L. Female external genitalia and müllerian duct derivatives in a 46,XY infant with the smith-lemli-Opitz syndrome. Am J Med Genet. 1987 Nov;28(3):723–731. doi: 10.1002/ajmg.1320280320. [DOI] [PubMed] [Google Scholar]
  2. Cotlier E., Rice P. Cataracts in the Smith-Lemli-Opitz syndrome. Am J Ophthalmol. 1971 Nov;72(5):955–959. doi: 10.1016/0002-9394(71)91696-5. [DOI] [PubMed] [Google Scholar]
  3. Cunniff C., Kratz L. E., Moser A., Natowicz M. R., Kelley R. I. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet. 1997 Jan 31;68(3):263–269. [PubMed] [Google Scholar]
  4. Curry C. J., Carey J. C., Holland J. S., Chopra D., Fineman R., Golabi M., Sherman S., Pagon R. A., Allanson J., Shulman S. Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet. 1987 Jan;26(1):45–57. doi: 10.1002/ajmg.1320260110. [DOI] [PubMed] [Google Scholar]
  5. Curry C. J., Stevenson R. E., Aughton D., Byrne J., Carey J. C., Cassidy S., Cunniff C., Graham J. M., Jr, Jones M. C., Kaback M. M. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet. 1997 Nov 12;72(4):468–477. doi: 10.1002/(sici)1096-8628(19971112)72:4<468::aid-ajmg18>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  6. Dallaire L., Mitchell G., Giguère R., Lefebvre F., Melançon S. B., Lambert M. Prenatal diagnosis of Smith-Lemli-Opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid. Prenat Diagn. 1995 Sep;15(9):855–858. doi: 10.1002/pd.1970150911. [DOI] [PubMed] [Google Scholar]
  7. Deaton J. G., Mendoza L. O. Smith-Lemli-Optiz syndrome in a 23-year-old man. Arch Intern Med. 1973 Sep;132(3):422–423. [PubMed] [Google Scholar]
  8. Elias E. R., Irons M. B., Hurley A. D., Tint G. S., Salen G. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) Am J Med Genet. 1997 Jan 31;68(3):305–310. doi: 10.1002/(sici)1096-8628(19970131)68:3<305::aid-ajmg11>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Fitzky B. U., Witsch-Baumgartner M., Erdel M., Lee J. N., Paik Y. K., Glossmann H., Utermann G., Moebius F. F. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8181–8186. doi: 10.1073/pnas.95.14.8181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fried K., Fraser W. I. Smith-Lemli-Opitz syndrome in an adult. J Ment Defic Res. 1972 Mar;16(1):30–34. doi: 10.1111/j.1365-2788.1972.tb01568.x. [DOI] [PubMed] [Google Scholar]
  11. Fukazawa R., Nakahori Y., Kogo T., Kawakami T., Akamatsu H., Tanae A., Hibi I., Nagafuchi S., Nakagome Y., Hirayama T. Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization. Acta Paediatr. 1992 Jun-Jul;81(6-7):570–572. doi: 10.1111/j.1651-2227.1992.tb12300.x. [DOI] [PubMed] [Google Scholar]
  12. Greene C., Pitts W., Rosenfeld R., Luzzatti L. Smith-Lemli-Opitz syndrome in two 46,XY infants with female external genitalia. Clin Genet. 1984 Apr;25(4):366–372. doi: 10.1111/j.1399-0004.1984.tb02006.x. [DOI] [PubMed] [Google Scholar]
  13. Hoefnagel D., Wurster D., Pomeroy J., Benz R. The Smith-Lemli-Opitz syndrome in an adult male. J Ment Defic Res. 1969 Dec;13(4):249–257. doi: 10.1111/j.1365-2788.1969.tb01089.x. [DOI] [PubMed] [Google Scholar]
  14. Hyett J. A., Clayton P. T., Moscoso G., Nicolaides K. H. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet. 1995 Sep 25;58(4):374–376. doi: 10.1002/ajmg.1320580415. [DOI] [PubMed] [Google Scholar]
  15. Irons M., Elias E. R., Abuelo D., Bull M. J., Greene C. L., Johnson V. P., Keppen L., Schanen C., Tint G. S., Salen G. Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet. 1997 Jan 31;68(3):311–314. [PubMed] [Google Scholar]
  16. Irons M., Elias E. R., Tint G. S., Salen G., Frieden R., Buie T. M., Ampola M. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am J Med Genet. 1994 May 1;50(4):347–352. doi: 10.1002/ajmg.1320500409. [DOI] [PubMed] [Google Scholar]
  17. Kelley R. I. A new face for an old syndrome. Am J Med Genet. 1997 Jan 31;68(3):251–256. doi: 10.1002/(sici)1096-8628(19970131)68:3<251::aid-ajmg1>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  18. Kelley R. I. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta. 1995 Apr 30;236(1):45–58. doi: 10.1016/0009-8981(95)06038-4. [DOI] [PubMed] [Google Scholar]
  19. Kelley R. I. RSH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. Am J Hum Genet. 1998 Aug;63(2):322–326. doi: 10.1086/301987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lachman M. F., Wright Y., Whiteman D. A., Herson V., Greenstein R. M. Brief clinical report: a 46,XY phenotypic female with Smith-Lemli-Opitz syndrome. Clin Genet. 1991 Feb;39(2):136–141. doi: 10.1111/j.1399-0004.1991.tb03000.x. [DOI] [PubMed] [Google Scholar]
  21. Lowry R. B., Yong S. L. Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet. 1980;5(2):137–143. doi: 10.1002/ajmg.1320050205. [DOI] [PubMed] [Google Scholar]
  22. McGaughran J. M., Clayton P. T., Mills K. A., Rimmer S., Moore L., Donnai D. Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet. 1995 Apr 10;56(3):269–271. doi: 10.1002/ajmg.1320560306. [DOI] [PubMed] [Google Scholar]
  23. McKeever P. A., Young I. D. Smith-Lemli-Opitz syndrome. II: A disorder of the fetal adrenals? J Med Genet. 1990 Jul;27(7):465–466. doi: 10.1136/jmg.27.7.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moebius F. F., Fitzky B. U., Lee J. N., Paik Y. K., Glossmann H. Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1899–1902. doi: 10.1073/pnas.95.4.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Natowicz M. R., Evans J. E. Abnormal bile acids in the Smith-Lemli-Opitz syndrome. Am J Med Genet. 1994 May 1;50(4):364–367. doi: 10.1002/ajmg.1320500413. [DOI] [PubMed] [Google Scholar]
  26. Ness G. C., Lopez D., Borrego O., Gilbert-Barness E. Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. Am J Med Genet. 1997 Jan 31;68(3):294–299. doi: 10.1002/(sici)1096-8628(19970131)68:3<294::aid-ajmg9>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  27. Nowaczyk M. J., Whelan D. T., Hill R. E. Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. Am J Med Genet. 1998 Aug 6;78(5):419–423. doi: 10.1002/(sici)1096-8628(19980806)78:5<419::aid-ajmg5>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  28. Opitz J. M. RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. Am J Med Genet. 1994 May 1;50(4):344–346. doi: 10.1002/ajmg.1320500408. [DOI] [PubMed] [Google Scholar]
  29. Rossiter J. P., Hofman K. J., Kelley R. I. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Am J Med Genet. 1995 Apr 10;56(3):272–275. doi: 10.1002/ajmg.1320560307. [DOI] [PubMed] [Google Scholar]
  30. Ryan A. K., Bartlett K., Clayton P., Eaton S., Mills L., Donnai D., Winter R. M., Burn J. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet. 1998 Jul;35(7):558–565. doi: 10.1136/jmg.35.7.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SMITH D. W., LEMLI L., OPITZ J. M. A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES. J Pediatr. 1964 Feb;64:210–217. doi: 10.1016/s0022-3476(64)80264-x. [DOI] [PubMed] [Google Scholar]
  32. Shefer S., Salen G., Batta A. K., Honda A., Tint G. S., Irons M., Elias E. R., Chen T. C., Holick M. F. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest. 1995 Oct;96(4):1779–1785. doi: 10.1172/JCI118223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tint G. S., Irons M., Elias E. R., Batta A. K., Frieden R., Chen T. S., Salen G. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 1994 Jan 13;330(2):107–113. doi: 10.1056/NEJM199401133300205. [DOI] [PubMed] [Google Scholar]
  34. Tint G. S., Salen G., Batta A. K., Shefer S., Irons M., Elias E. R., Abuelo D. N., Johnson V. P., Lambert M., Lutz R. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr. 1995 Jul;127(1):82–87. doi: 10.1016/s0022-3476(95)70261-x. [DOI] [PubMed] [Google Scholar]
  35. Tsukahara M., Fujisawa K., Yamamoto K., Hasui M., Saito C., Yamamaka T., Honda A., Honda M., Tint G. S., Salen G. Smith-Lemli-Opitz syndrome in Japan. Am J Med Genet. 1998 Jan 6;75(1):118–119. [PubMed] [Google Scholar]
  36. Waterham H. R., Wijburg F. A., Hennekam R. C., Vreken P., Poll-The B. T., Dorland L., Duran M., Jira P. E., Smeitink J. A., Wevers R. A. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet. 1998 Aug;63(2):329–338. doi: 10.1086/301982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. de Die-Smulders C., Fryns J. P. Smith-Lemli-Opitz syndrome: the changing phenotype with age. Genet Couns. 1992;3(2):77–82. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES